Chosen Diagnostics receives a $2.1M award from the National Institutes of Health September 2021 to support development of NECDetect and clinical testing for FDA approval. By Robert Tucci 30 October, 2021 No Comments
Texas HALO Fund launches Fund IV targeting new investors seeking early stage investment exposure and diversification By Robert Tucci 2 November, 2020 No Comments
Texas Halo Fund launches HALO IV targeting early stage investors. By Robert Tucci 26 October, 2020 No Comments
